Cargando…

Overcoming the impact of the COVID‐19 pandemic on oncology early phase trials and drug development in Asia—Experiences and perspectives of the Asian Oncology Early Phase 1 Consortium

AIM: The significance and prioritization of early phase oncology trial continuation during a global pandemic is unknown. This study reported the outcomes, multiple challenges, and broad recommendations associated with the impact of the novel coronavirus disease 2019 (COVID‐19) on oncology early phas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shimizu, Toshio, Kim, Dong‐Wan, Loong, Herbert H., Lin, Chia‐Chi, Ng, Matthew CH, Yamamoto, Noboru, Ma, Brigette, Tan, Daniel SW
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014030/ https://www.ncbi.nlm.nih.gov/pubmed/33502085 http://dx.doi.org/10.1111/ajco.13510

Ejemplares similares

Precision Oncology for Cancer Immunotherapies in Early-Phase Clinical Trials
por: Paliard, Xavier, et al.
Publicado: (2019)

Design considerations for early-phase clinical trials of immune-oncology agents
por: Wages, Nolan A., et al.
Publicado: (2018)

Early phase clinical trials in oncology: realising the potential of seamless designs
por: Jaki, Thomas, et al.
Publicado: (2023)

Advancing Cardio-Oncology in Asia
por: Ng, Choon Ta, et al.
Publicado: (2022)

Radiation Oncology Research in Asia: Current Status and a Peep Into the Future From the Federation of Asian Organizations for Radiation Oncology
por: Chopra, Supriya, et al.
Publicado: (2023)

Nurses of Asia: Reflection from Asian Oncology Nursing Society Conference 2015
por: Camarillo, Jimvert I.
Publicado: (2016)

Predictors of early treatment discontinuation in patients enrolled on Phase I oncology trials
por: Hyman, David M., et al.
Publicado: (2015)

Research Biopsies in the Context of Early Phase Oncology Studies: Clinical and Ethical Considerations
por: Saggese, Matilde, et al.
Publicado: (2013)

Seamless Designs: Current Practice and Considerations for Early-Phase Drug Development in Oncology
por: Hobbs, Brian P, et al.
Publicado: (2018)

Integration of healthy volunteers in early phase clinical trials with immuno-oncological compounds
por: Radanovic, Igor, et al.
Publicado: (2022)

Bayesian dose regimen assessment in early phase oncology incorporating pharmacokinetics and pharmacodynamics
por: Gerard, Emma, et al.
Publicado: (2021)

The treatment landscape of advanced angiosarcoma in Asia—A multi‐national collaboration from the Asian Sarcoma Consortium
por: Chen, Tom Wei‐Wu, et al.
Publicado: (2021)

Symposium: “Oncology Leadership in Asia”
por: Noh, Dong-Young, et al.
Publicado: (2017)

Tissue-Based Approaches to Study Pharmacodynamic Endpoints in Early Phase Oncology Clinical Trials
por: Ang, Joo Ern, et al.
Publicado: (2012)

Impact of race on dose selection of molecular-targeted agents in early-phase oncology trials
por: Yokota, Tomoya, et al.
Publicado: (2018)

Survival in Early Phase Immuno-Oncology Trials: Development and Validation of a Prognostic Index
por: Day, Daphne, et al.
Publicado: (2019)

Impact of a pandemic on surgical neuro-oncology—maintaining functionality in the early phase of crisis
por: Hameed, N. U. Farrukh, et al.
Publicado: (2021)

An overview of the BOIN design and its current extensions for novel early-phase oncology trials
por: Ananthakrishnan, Revathi, et al.
Publicado: (2022)

Surviving the COVID-19 pandemic: early response of a gynecologic oncology unit in Singapore
por: Lim, Yu Hui, et al.
Publicado: (2020)

Early-Phase Oncology Research Training (EFFORT) program: a Hengrui-USCACA joint scholarship
por: Yan, Li, et al.
Publicado: (2015)

Clinical Predictors of Early Trial Discontinuation for Patients Participating in Phase I Clinical Trials in Oncology
por: Douma, Joeri A. J., et al.
Publicado: (2021)

Looking ahead in early-phase trial design to improve the drug development process: examples in oncology
por: Vanderbeek, Alyssa M., et al.
Publicado: (2023)

Microtubule-targeting agents in oncology and therapeutic potential in hepatocellular carcinoma
por: Loong, Herbert H, et al.
Publicado: (2014)

Global Implementation of Precision Oncology
por: Yam, Clinton, et al.
Publicado: (2021)

Endpoint surrogacy in oncology Phase 3 randomised controlled trials
por: Zhang, Jianrong, et al.
Publicado: (2020)

Report of chronic myelogenous leukemia in chronic phase from, Asian Institute of Oncology, Mumbai, 2002-2010
por: Bansal, Shweta, et al.
Publicado: (2013)

Ocular toxicity of investigational anti-cancer drugs in early phase clinical trials
por: Takamizawa, Shigemasa, et al.
Publicado: (2022)

Bayesian modeling of a bivariate toxicity outcome for early phase oncology trials evaluating dose regimens
por: Gerard, Emma, et al.
Publicado: (2021)

Inequality factors in access to early-phase clinical trials in oncology in France: results of the EGALICAN-2 study
por: Charton, E., et al.
Publicado: (2023)

The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women’s cancer research organization
por: Tan, David, et al.
Publicado: (2023)

The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women’s cancer research organization
por: Tan, David, et al.
Publicado: (2023)

Operational Challenges of an Asia-Pacific Academic Oncology Clinical Trial
por: Day, Daphne, et al.
Publicado: (2023)

Establishment of the Asia Oncology Nursing Society (AONS)
por: Onishi, Kazuko
Publicado: (2014)

The Journal of Gynecologic Oncology and the Asian Society of Gynecologic Oncology: the history, the present and the future
por: Chang, Ki-Hong, et al.
Publicado: (2012)

Stopping rules employing response rates, time to progression, and early progressive disease for phase II oncology trials
por: Goffin, John R, et al.
Publicado: (2011)

Early mortality and overall survival in oncology phase I trial participants: can we improve patient selection?
por: Chau, Nicole G, et al.
Publicado: (2011)

Impact of ASA-score, age and learning curve on early outcome in the initiation phase of an oncological robotic colorectal program
por: Sarikaya, Hülya, et al.
Publicado: (2020)

Comparison of Various Phase I Combination Therapy Designs in Oncology for Evaluation of Early Tumor Shrinkage Using Simulations
por: Seurat, Jérémy, et al.
Publicado: (2020)

13: Burnout and Resiliency Assessment of Canadian Radiation Oncology Trainees During the Early Phase of the COVID-19 Pandemic
por: Wu, Che Hsuan David, et al.
Publicado: (2021)

Efficacy gap between phase II and subsequent phase III studies in oncology
por: Vreman, Rick A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m61s40orhvpi62n4knfpat4j60